CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies [Yahoo! Finance]
AstraZeneca PLC Ordinary Shares (AZN)
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
CSPC Pharmaceutical Group and AstraZeneca have entered a global collaboration and licensing deal to co develop long acting therapies for obesity and type 2 diabetes. The partnership covers multiple programs that combine advanced delivery technologies with AI driven drug discovery. The agreement gives AstraZeneca access to CSPC's proprietary platforms while positioning CSPC as a more visible player in metabolic disease treatments worldwide. CSPC Pharmaceutical Group, traded as SEHK:1093, is drawing fresh attention with this deal as investors look at how its drug discovery and delivery platforms might scale beyond China. The current share price stands at HK$9.6, with a 121.4% return over the past year and a 38.1% return over five years, indicating a strong rerating phase over those periods. Over shorter time frames, the shares show a 13.9% return over 30 days and a 13.2% return year to date, with a 2.1% decline over the past week. For investors, a central question is how this c
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC Ordinary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- Shell chief exec to become one of FTSE's best paid bosses [Yahoo! Finance]Yahoo! Finance
- Why pharma manufacturers are still investing in Europe [Yahoo! Finance]Yahoo! Finance
- IonQ to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]Yahoo! Finance
- AstraZeneca Oncology Advances Gain Momentum With New Cancer Approvals In Focus [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 2/3/26 - Form S-8
- 2/3/26 - Form 6-K
- 2/2/26 - Form 6-K
- AZN's page on the SEC website